Compound Overview Class of Compound: Peptide Mechanism of Action: GHK-Cu is said to stimulate the synthesis and breakdown of collagen and glycosaminoglycans, as well as modulating the activity of metalloproteinases and their inhibitors
Their compounding status under federal law is still being determined: removal from the Category 2 restricted list takes effect April 23, 2026, and the FDAs Pharmacy Compounding Advisory Committee will review whether to officially clear any of them at its July 23-24, 2026 meeting
Proper reconstitution, refrigerated storage, and sterile injection practices are essential for safety and efficacy
MOTS-c Pathway (Systemic Energy Sensor): Cellular Stress / Exercise Mitochondria release MOTS-c Travels to Nucleus Activates AMPK Result: Increased Insulin Sensitivity + Enhanced ATP Production + Systemic Fat Oxidation 5-Amino-1MQ Pathway (Targeted Fat Burner): High-Fat Diet / Aging 5-Amino-1MQ enters Adipocytes (Fat Cells) Blocks NNMT Enzyme Result: NAD+ Levels Skyrocket Forced Lipolysis (Fat Burning) + Prevention of Fat Storage Why MOTS-c Might Be "Better" Experimental findings show that MOTS-c provides broad, systemic metabolic benefits
One review describes BPC-157 as active across the GI tract and studied in IBD, including ulcerative colitis, in BPC-157 in IBD